At CMC Biologics, new stories are continually emerging. Click on the stories below to find out more about us.
January 5, 2012
CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
November 9, 2011
CMC Biologics, Thermo Fisher Scientific, Applikon Biotechnology and BioProcess International Highlight Industry and Academic Expertise at Pharmaceutical Manufacture Seminar on Single-Use Technology
October 26, 2011
CMC Biologics Announces Agreement with Daiichi Sankyo to Develop and Manufacture Antibodies
September 23, 2011
Bothell's CMC Biologics Expands Facility to Develop Drugs for Clinical Trials – The Herald
September 22, 2011
Director of Commerce, Rogers Weed, Presided Over Ribbon Cutting Ceremony Celebrating Opening of Expanded Manufacturing Facility at CMC Biologics
September 21, 2011
Biotech Drug Factory Cultivates New Business – Seattle Times
September 20, 2011
CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001
September 7, 2011
CMC Biologics Licenses its CHEF1® Expression System to Oxford BioTherapeutics
September 1, 2011
CMC Biologics Adds 2,000 Liter Single-Use Bioreactor at its Copenhagen Manufacturing Facility
August 12, 2011
CMC Biologics Announces Appointment of New CFO
June 22, 2011
CMC Biologics Expands its Production Facility and Rebrands it's Corporate Identity
May 2, 2011
CMC Biologics Announces Appointment of New CEO – Claes Glassell, Former CEO of Cerus Corporation to Take Helm
September 9, 2010
Edimer Pharmaceuticals and CMC Biologics Announce Agreement to Manufacture EDI200 Recombinant Protein
August 24, 2010
CMC Biologics Completes First Stage of Expansion with Addition of Single-use Facility
July 27, 2010
ProtAffin AG Signs Manufacturing Contract for PA401 with CMC Biologics A/S
July 7, 2010
CMC ICOS Mounts Comeback, Resumes Hiring, After Pausing During the Downturn – Xconomy